# A Research Study for Patients With Overactive Bladder

> **NCT00168454** · PHASE2 · COMPLETED · sponsor: **Allergan** · enrollment: 313 (actual)

## Conditions studied

- Overactive Bladder
- Urinary Incontinence

## Interventions

- **BIOLOGICAL:** botulinum toxin Type A
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00168454
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2008-01
- **Final completion:** 2008-06
- **Target enrollment:** 313 (ACTUAL)
- **Last updated:** 2013-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00168454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00168454, "A Research Study for Patients With Overactive Bladder". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00168454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*